- All sections
- A - Human necessities
- A61P - Specific therapeutic activity of chemical compounds or medicinal preparations
- A61P 25/14 - Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
Patent holdings for IPC class A61P 25/14
Total number of patents in this class: 1871
10-year publication summary
|
80
|
125
|
158
|
151
|
143
|
168
|
150
|
142
|
140
|
62
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Takeda Pharmaceutical Company Limited | 2718 |
31 |
| Taisho Pharmaceutical Co., Ltd. | 855 |
30 |
| Neurocrine Biosciences, Inc. | 445 |
28 |
| Auspex Pharmaceuticals, LLC | 66 |
23 |
| Daiichi Sankyo Company, Limited | 1890 |
21 |
| Sage Therapeutics, Inc. | 332 |
19 |
| Prilenia Neurotherapeutics Ltd. | 97 |
19 |
| Kyoto University | 2898 |
17 |
| The Regents of the University of California | 20590 |
16 |
| Sumitomo Pharma Co., Ltd. | 550 |
14 |
| F. Hoffmann-La Roche AG | 7847 |
13 |
| PTC Therapeutics, Inc. | 476 |
13 |
| Sumitomo Dainippon Pharma Co., Ltd. | 211 |
13 |
| Praxis Precision Medicines, Inc. | 224 |
12 |
| Duke University | 3172 |
11 |
| Vanderbilt University | 1991 |
11 |
| Voyager Therapeutics, Inc. | 283 |
11 |
| Adeptio Pharmaceuticals Limited | 19 |
11 |
| Hoffmann-La Roche Inc. | 3726 |
10 |
| Ovid Therapeutics Inc | 173 |
10 |
| Other owners | 1538 |